Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 982 participants.

Also called NCT03783429

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 982 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03783429
Other papers using this trial's data
  • Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial Nature medicine, 2026-07 DOI, PubMed 42108270, PMC13375525 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03783429. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-01 (actual); primary completion 2025-11-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
Acronym
DECISION
Condition
Heart Failure
Intervention (Drug)
Digoxin
Intervention (Drug)
Placebos
Lead sponsor
University Medical Center Groningen (class: other)
Collaborator
Disphar International B.V. (class: industry)
Collaborator
Teva Nederland BV (class: not stated)
Collaborator
Tiofarma BV (class: not stated)
Collaborator
Netherlands Heart Foundation (class: other)
Collaborator
Werkgroep Cardiologische centra Nederland (class: not stated)

Record details

Record id
cardio:ct-nct03783429
Content hash
41a779d9bef0890ddac134e593019e5447e0edc9b1338d24b88551fa62a6aec5